Zaleplon pharmacokinetics and absolute bioavailability.
作者： Amy S. Rosen , Philippe Fournié , Mona Darwish , Philippe Danjou , Steven M. Troy
DOI: 10.1002/(SICI)1099-081X(199904)20:3<171::AID-BDD169>3.0.CO;2-K
关键词: Bioavailability 、 Nonbenzodiazepine 、 Oral administration 、 Crossover study 、 Hypnotic 、 Zaleplon 、 Pharmacology 、 Pharmacokinetics 、 Medicine 、 Volume of distribution
摘要: … Zaleplon pharmacokinetics were determined in 20 subjects (ten men and ten … of zaleplon administered in this study were safe and well-tolerated. Following iv administration, zaleplon …
sci-hub.se 参考文章(5)
Kimberly E. Vanover, James E. Barrett, Evaluation of the discriminative stimulus effects of the novel sedative-hypnotic CL 284,846 Psychopharmacology. ,vol. 115, pp. 289- 296 ,(1994) , 10.1007/BF02245068
Kimberly E. Vanover, Richard M. Mangano, James E. Barrett, CL 284,846, a novel sedative‐hypnotic: Evaluation of its metabolites for pharmacological activity in vitro and in vivo Drug Development Research. ,vol. 33, pp. 39- 45 ,(1994) , 10.1002/DDR.430330107
Bernard Beer, John R. Ieni, Wen-Hui Wu, Donald Clody, Peter Amorusi, James Rose, Time Mant, Jacques Gaudreault, Allen Cato, Warren Stern, A Placebo-Controlled Evaluation of Single, Escalating Doses of CL 284,846, a Non-Benzodiazepine Hypnotic The Journal of Clinical Pharmacology. ,vol. 34, pp. 335- 344 ,(1994) , 10.1002/J.1552-4604.1994.TB02002.X
A. B. RENWICK, H. MISTRY, S. E. BALL, D. G. WALTERS, J. KAO, B. G. LAKE, Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms Xenobiotica. ,vol. 28, pp. 337- 348 ,(1998) , 10.1080/004982598239452
Pharmacokinetics, Second Edition CRC Press. ,(1982) , 10.1201/B14095